India’s Sun Pharmaceuticals Ltd said on Monday that it has entered into agreement to acquire a 16.7 per cent stake in US company Lyndra Therapeutics Inc for $30 million.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.